Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to $2.1 million.

  • AC Immune's Net Cash Flow rose 11118.52% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.2 million, marking a year-over-year decrease of 19667.1%. This contributed to the annual value of -$46.3 million for FY2024, which is 18545.77% down from last year.
  • Latest data reveals that AC Immune reported Net Cash Flow of $2.1 million as of Q3 2025, which was up 11118.52% from $9.0 million recorded in Q2 2025.
  • In the past 5 years, AC Immune's Net Cash Flow ranged from a high of $54.0 million in Q4 2023 and a low of -$51.2 million during Q2 2021
  • Moreover, its 5-year median value for Net Cash Flow was -$11.6 million (2021), whereas its average is -$7.4 million.
  • As far as peak fluctuations go, AC Immune's Net Cash Flow tumbled by 140862.36% in 2021, and later skyrocketed by 51323.58% in 2023.
  • Quarter analysis of 5 years shows AC Immune's Net Cash Flow stood at -$11.7 million in 2021, then decreased by 11.48% to -$13.1 million in 2022, then soared by 513.24% to $54.0 million in 2023, then plummeted by 95.96% to $2.2 million in 2024, then decreased by 2.93% to $2.1 million in 2025.
  • Its last three reported values are $2.1 million in Q3 2025, $9.0 million for Q2 2025, and -$18.5 million during Q1 2025.